Physician profile
Patrick Mcginn
NPI 1861868549
$72,452.68
in general payments reported to CMS, 2019-2025
42 companies · $37K in 2025
The $37K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,012 · 2022: $11K · 2023: $9,172 · 2024: $12K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $17K · Travel and Lodging: $9,756 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,862.50 |
| Food and Beverage | $17,148.23 |
| Travel and Lodging | $9,756.46 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $13,847.31 | 2021-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $13,525.88 | 2023-2025 | Prospera, Biotronik |
| Stryker Corporation | $13,461.89 | 2024-2025 | Mild Device Kit, Spinejack, Omnicurve |
| Spr Therapeutics, INC | $9,848.47 | 2021-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $6,853.53 | 2022-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $2,571.79 | 2021-2025 | General - Pain Management, Intracept, Intracept Rf Probe |
| Abbott Laboratories | $2,169.04 | 2021-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,595.07 | 2021-2024 | Senza |
| Collegium Pharmaceutical, INC. | $1,018.95 | 2021-2025 | Belbuca |
| Relievant Medsystems, INC. | $873.48 | 2022-2023 | Intracept |
| Abbvie INC. | $797.86 | 2021-2025 | |
| Spinal Simplicity, LLC | $782.98 | 2024-2025 | Ha Minuteman G3-R |
| Painteq LLC | $652.42 | 2021-2022 | |
| Foundation Fusion Solutions, LLC | $580.69 | 2024-2025 | |
| Averitas Pharma INC. | $490.49 | 2023-2025 | Qutenza |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $467.38 | 2021-2024 | Reactiv8 |
| Horizon Therapeutics Plc | $441.28 | 2021-2022 | |
| Nalu Medical, INC. | $338.75 | 2022-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $335.45 | 2022-2025 | Inceptiv, Intellis Adaptivestim, Vanta Adaptivestim |
| Globus Medical, INC. | $300.72 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $179.35 | 2021 | |
| Grt US Holding, INC. | $166.13 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $154.10 | 2023-2024 | Horizant, Horizant |
| Valinor Pharma, LLC | $133.62 | 2024 | Movantik |
| Ibsa Pharma INC. | $124.46 | 2021-2024 | Tirosint, Licart, Licart |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.37 | 2021-2025 | Relistor |
| Almatica Pharma LLC | $94.35 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $68.46 | 2024-2025 | |
| Depuy Synthes Sales INC. | $51.75 | 2025 | Monovisc, Orthovisc |
| Si-Bone, INC. | $51.59 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $49.19 | 2023 | Zilretta, Iovera, Exparel |
| Kowa Pharmaceuticals America, INC. | $40.85 | 2023 | Seglentis |
| Uswm, LLC | $40.51 | 2021-2022 | |
| Protega Pharmaceutials INC | $35.38 | 2025 | Roxybond |
| Virtus Pharmaceuticals LLC | $32.59 | 2025 | Levorphanol Tartrate |
| Indivior INC. | $32.15 | 2022-2025 | Sublocade |
| Pfizer INC. | $29.73 | 2021-2024 | |
| Curonix LLC | $29.52 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cumberland Pharmaceuticals, INC. | $19.12 | 2025 | Kristalose |
| Allergan, INC. | $15.12 | 2021 | |
| Bioventus LLC | $13.88 | 2023 | Gelsyn-3 |
| Biohaven Pharmaceutical Holding Company LTD. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcginn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.